Physician profile
Glen Brooks
NPI 1588637847
$77,676.75
in general payments reported to CMS, 2019-2025
9 companies · $1,281 in 2025
The $1,281 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $627 · 2020: $25.53 · 2021: $59K · 2022: $13K · 2023: $2,344 · 2024: $1,506 · 2025: $1,281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,287 · Food and Beverage: $1,844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,286.60 |
| Food and Beverage | $1,844.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $70,775.25 | 2019-2023 | |
| Abbvie INC. | $3,516.18 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Sientra, INC. | $2,386.40 | 2019-2021 | |
| Revance Therapeutics, INC. | $689.08 | 2024-2025 | Daxxify |
| Solta Medical, A Division of Bausch Health US, LLC | $110.55 | 2025 | Clear+Brilliant |
| Tela Bio, INC. | $77.98 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Urogen Pharma, INC. | $57.79 | 2025 | |
| Calyxo, INC. | $46.49 | 2025 | Cvac Aspiration System |
| Pacira Pharmaceuticals Incorporated | $17.03 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glen Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.